Canadian Cancer Trials Group (CCTG) IND211: A randomized trial of pelareorep (Reolysin) in patients with previously treated advanced or metastatic non-small cell lung cancer receiving standard salvage therapy

References

Page 1

	Year	Citations
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer Martin Reck, Delvys Rodríguez‐Abreu, Andrew Robinson, New England Journal of Medicine	2016	9.8K
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial Roy S. Herbst, Paul Baas, Dong‐Wan Kim, The Lancet Pembrolizumab Versus DocetaxelOncologyClinical TrialsImmune Checkpoint InhibitorPharmacotherapy	2015	6.4K
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy Nasser H. Hanna, Frances A. Shepherd, Frank V. Fossella, Journal of Clinical Oncology	2004	2.4K
Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy Frances A. Shepherd, Janet Dancey, Rodryg Ramlau, Journal of Clinical Oncology	2000	2.2K
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer Christopher G. Azzoli, Sherman Baker, Sarah Temin, Journal of Clinical Oncology Tumor MicroenvironmentMolecular MarkersMedicineCancer ManagementClinical Trials	2009	912
Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Gregory A. Masters, Sarah Temin, Christopher G. Azzoli, Journal of Clinical Oncology Low Pd-l1 ExpressionCancer TherapeuticsPd-l1 ExpressionMedicineCancer Management	2015	847
Ras Transformation Mediates Reovirus Oncolysis by Enhancing Virus Uncoating, Particle Infectivity, and Apoptosis-dependent Release Paola Marcato, Maya Shmulevitz, Da Pan, Molecular Therapy	2007	170
Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells Shizuko Sei, Jodie Mussio, Quan‐en Yang, Molecular Cancer	2009	117
Oncolytic reovirus in combination with chemotherapy in metastatic or recurrent non–small cell lung cancer patients with <scp>K</scp>RAS‐activated tumors Miguel A. Villalona‐Calero, Elaine T. Lam, Gregory A. Otterson, Cancer	2015	67

Page 1